4//SEC Filing
WORLAND STEPHEN T 4
Accession 0001209191-23-045499
CIK 0001828522other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 8:00 AM ET
Size
7.8 KB
Accession
0001209191-23-045499
Insider Transaction Report
Form 4
WORLAND STEPHEN T
DirectorPresident and Chief Executive
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-08-11−33,799→ 0 totalExercise: $0.52Exp: 2023-12-16→ Common Stock (33,799 underlying) - Exercise/Conversion
Common Stock
2023-08-11$0.52/sh+33,799$17,575→ 261,225 total
Holdings
- 562,339(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The stock option vests 25% on December 17, 2014, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
eFFECTOR Therapeutics, Inc.
CIK 0001828522
Entity typeother
Related Parties
1- filerCIK 0001283307
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 8:00 AM ET
- Size
- 7.8 KB